FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (I), or a pharmaceutically acceptable salt thereof, where R1 and R2 are independently selected from a group consisting of hydrogen, unsubstituted (C1-C8)alkyl, -COR5 and -CO2R6; R1 and R2 can also be cyclised to form a substituted or unsubstituted 4-, 5- or 6-member ring, selected from morpholine, piperidine, pyrrolidine, piperazine, azetidine, 4-methylpiperazine; R3 is nitro or nitroso; R4 is selected from a group consisting of ethynyl, propynyl or cyano; R5 is selected from a group consisting of an unsubstituted (C1-C8)alkyl or unsubstituted aryl; R6 is unsubstituted (C1-C8)alkyl. The invention also relates to methods of producing the compound of formula (I) (versions). The compounds of formula (I) are intended for preparing a pharmaceutical composition or a medicinal agent for treating a disease associated with a poly (ADP-ribose) polymerase (PARP) inhibitor, or for treating cancer, which contains an effective dose of a compound of formula (I) or a pharmaceutically acceptable salt thereof.
EFFECT: benzamide derivatives intended for producing a medicinal agent for treating a disease associated with a poly (ADP-ribose) polymerase (PARP) inhibitor, or cancer.
20 cl, 2 tbl, 37 ex
Title | Year | Author | Number |
---|---|---|---|
INDAZOLE COMPOUNDS AS FGFR KINASE INHIBITORS, PREPARATION AND USE THEREOF | 2015 |
|
RU2719428C2 |
ANELLATED 9-HYDROXY-1,8-DIOXO-1,3,4,8-TETRAHYDRO-2H-PYRIDO[1,2-A]PYRAZINE-7-CARBOXAMIDES - INTEGRASE INHIBITORS, METHODS FOR PREPARING AND USING THEREOF | 2019 |
|
RU2717101C1 |
BENZO-DERIVATIVES WITH SIX-MEMBERED RING AS DPP-4 INHIBITOR AND USE THEREOF | 2015 |
|
RU2702644C2 |
NITROGEN-CONTAINING HETEROCYCLIC AROMATIC COMPOUND, METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION BASED THEREON AND USE THEREOF | 2017 |
|
RU2729999C1 |
DIARYL HYDANTOINS | 2011 |
|
RU2638833C2 |
TRYPTOLIDE DERIVATIVE, METHOD FOR ITS PREPARATION AND APPLICATION | 2018 |
|
RU2753036C1 |
5-AROMATIC ALKYNYL-SUBSTITUTED BENZAMIDE COMPOUND AND METHOD FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF | 2016 |
|
RU2695371C2 |
NOVEL 1,2,4-TRIAZOLE COMPOUNDS, METHODS FOR THEIR PREPARING AND MEDICAMENTS CONTAINING THEREOF | 2002 |
|
RU2293733C2 |
HETEROCYCLIC AMIDE COMPOUND, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, METHOD FOR PREPARATION AND USE THEREOF | 2020 |
|
RU2823875C1 |
SUBSTITUTED N-{3-[4-(1-METHYL-1H-INDOL-3-YL)PYRIMIDIN-2-YLAMINO]-4-METHOXYPHENYL}-AMIDES AS MODULATORS OF EGFR, APPLICABLE FOR TREATING CANCER | 2015 |
|
RU2606949C9 |
Authors
Dates
2015-10-20—Published
2011-11-03—Filed